JENNIFER GARDNER: Open Payments
NPI 1205221587 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,634 in 68 payments from 12 companies in 2025. Trend: 2023 $2,184 · 2024 $1,138 · 2025 $1,634
Food & beverage: $1,634
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $408 |
| GlaxoSmithKline, LLC. | 15 | $259 |
| CSL Behring | 10 | $216 |
| Novartis Pharmaceuticals Corporation | 7 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $114 |
| GENZYME CORPORATION | 4 | $110 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $87 |
| Janssen Biotech, Inc. | 4 | $76 |
| Genentech USA, Inc. | 3 | $70 |
Products named: DUPIXENT, TRELEGY ELLIPTA, FASENRA, BREZTRI, Andembry, NUCALA, Haegarda, CUVITRU.
Industry payments across IL — which companies pay providers there.
